Catalent has officially opened its new global corporate headquarters in Tampa, Florida, marking a significant shift from its previous base in Somerset, New Jersey. This strategic relocation, which also includes a new corporate office in Bridgewater, NJ, signals Catalent’s commitment to enhancing its operational footprint in a region where it has established a robust presence.
The new headquarters complements Catalent’s existing 500,000-square-foot facility in St. Petersburg, which employs over 630 individuals and serves as the primary site for softgel development and manufacturing in North America. According to Alessandro Maselli, president and CEO, this expansion underscores the company’s long-term investment in the Tampa area, where it has been operational for nearly fifty years, providing a range of services from early-phase development to full-scale commercial manufacturing.
This move not only strengthens Catalent’s capabilities but also positions the company to better serve its clients in the growing biopharmaceutical sector, reflecting a broader trend of companies seeking to optimize their geographic and operational strategies in response to market demands.
Use the database as your supply chain compass →
